Non-screw based expandable cage technology
Total Trials
10
As Lead Sponsor
4
As Collaborator
6
Total Enrollment
10,634
NCT00984048
Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
Phase: N/A
Role: Collaborator
Start: Aug 31, 2009
Completion: Aug 31, 2019
NCT01276899
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Start: Sep 30, 2010
Completion: Not specified
NCT02355171
Personalize My Treatment (PMT) Registry
Role: Lead Sponsor
Start: Nov 30, 2015
NCT04874064
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
Start: Dec 5, 2019
Completion: Jun 30, 2023
NCT04470765
Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence
Start: Sep 15, 2020
Completion: Dec 31, 2020
NCT04566458
RWD Study in HER2+ mBC Patients in Third-Line Therapy
Start: Oct 1, 2020
Completion: May 30, 2021
NCT04409925
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)
Phase: Phase 1
Start: Dec 25, 2020
Completion: Aug 1, 2021
NCT04564079
An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network
Start: Jun 1, 2021
Completion: Nov 21, 2023
NCT05287620
Objective, Passive Assessment of LRRK2 Carriers
Start: Apr 27, 2022
Completion: May 7, 2024
NCT05358639
Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
Start: Nov 9, 2022
Completion: Apr 28, 2025
Loading map...